266 related articles for article (PubMed ID: 15677765)
1. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.
Wang FS; Lin CL; Chen YJ; Wang CJ; Yang KD; Huang YT; Sun YC; Huang HC
Endocrinology; 2005 May; 146(5):2415-23. PubMed ID: 15677765
[TBL] [Abstract][Full Text] [Related]
2. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
[TBL] [Abstract][Full Text] [Related]
3. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
Wang FS; Ko JY; Yeh DW; Ke HC; Wu HL
Endocrinology; 2008 Apr; 149(4):1793-801. PubMed ID: 18174290
[TBL] [Abstract][Full Text] [Related]
5. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
Ko JY; Chuang PC; Chen MW; Ke HC; Wu SL; Chang YH; Chen YS; Wang FS
Bone; 2013 Dec; 57(2):468-75. PubMed ID: 24096265
[TBL] [Abstract][Full Text] [Related]
7. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
8. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
9. [Wnt signaling and glucocorticoid-induced osteoporosis].
Ohnaka K
Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
Ko JY; Wu RW; Kuo SJ; Chen MW; Yeh DW; Ke HC; Wu SL; Wang FS
Arthritis Rheum; 2012 Apr; 64(4):1204-14. PubMed ID: 22127784
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.
Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY
J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569
[TBL] [Abstract][Full Text] [Related]
13. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis.
Ohnaka K; Taniguchi H; Kawate H; Nawata H; Takayanagi R
Biochem Biophys Res Commun; 2004 May; 318(1):259-64. PubMed ID: 15110782
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
Wang FS; Chuang PC; Lin CL; Chen MW; Ke HJ; Chang YH; Chen YS; Wu SL; Ko JY
Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.
Liu G; Bafico A; Aaronson SA
Mol Cell Biol; 2005 May; 25(9):3475-82. PubMed ID: 15831454
[TBL] [Abstract][Full Text] [Related]
18. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
19. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
Day TF; Guo X; Garrett-Beal L; Yang Y
Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
